Universal Superspeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 27-10-2024
- Paid Up Capital ₹ 24.08 Cr
as on 27-10-2024
- Company Age 1 Year 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.67 Cr
as on 27-10-2024
About Universal Superspeciality Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 24.08 Cr.
The company currently has active open charges totaling ₹17.67 Cr.
The Key Managerial Personnel (KMP) at Universal Superspeciality Hospital Limited India is Stuti Shah as COMPANY SECRETARY. Dipak Viradia, Hareshkumar Vastarpara, Dhavalkumar Patel, and Two other members serve as directors at the Company.
- CIN/LLPIN
U82990GJ2023PLC139251
- Company No.
139251
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2023
- Date of AGM
06 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Universal Superspeciality Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Stuti Shah | Company Secretary | 18-Jul-2024 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipak Viradia  | Director | 16-Mar-2023 | Current |
| Hareshkumar Vastarpara | Director | 16-Mar-2023 | Current |
| Dhavalkumar Patel | Director | 16-Mar-2023 | Current |
| Sanjay Vaghani | Director | Current | |
| Mishal Shah | Director | Current |
Financial Performance of Universal Superspeciality Hospital.
Universal Superspeciality Hospital Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Universal Superspeciality Hospital?
In 2023, Universal Superspeciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 May 2024 | ₹2.89 Cr | Open |
Yes Bank Limited Creation Date: 08 Apr 2024 | ₹1.16 Cr | Open |
Others Creation Date: 16 Dec 2023 | ₹3.67 Cr | Open |
How Many Employees Work at Universal Superspeciality Hospital?
Unlock and access historical data on people associated with Universal Superspeciality Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Universal Superspeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Superspeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
